These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 29976574)

  • 1. Replication Stress Drives Constitutive Activation of the DNA Damage Response and Radioresistance in Glioblastoma Stem-like Cells.
    Carruthers RD; Ahmed SU; Ramachandran S; Strathdee K; Kurian KM; Hedley A; Gomez-Roman N; Kalna G; Neilson M; Gilmour L; Stevenson KH; Hammond EM; Chalmers AJ
    Cancer Res; 2018 Sep; 78(17):5060-5071. PubMed ID: 29976574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.
    Ning J; Wakimoto H; Peters C; Martuza RL; Rabkin SD
    J Natl Cancer Inst; 2017 Mar; 109(3):1-13. PubMed ID: 28376211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMI1 confers radioresistance to normal and cancerous neural stem cells through recruitment of the DNA damage response machinery.
    Facchino S; Abdouh M; Chatoo W; Bernier G
    J Neurosci; 2010 Jul; 30(30):10096-111. PubMed ID: 20668194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma.
    Qazi MA; Vora P; Venugopal C; Adams J; Singh M; Hu A; Gorelik M; Subapanditha MK; Savage N; Yang J; Chokshi C; London M; Gont A; Bobrowski D; Grinshtein N; Brown KR; Murty NK; Nilvebrant J; Kaplan D; Moffat J; Sidhu S; Singh SK
    Cancer Res; 2018 Sep; 78(17):5023-5037. PubMed ID: 29945963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase.
    Carruthers R; Ahmed SU; Strathdee K; Gomez-Roman N; Amoah-Buahin E; Watts C; Chalmers AJ
    Mol Oncol; 2015 Jan; 9(1):192-203. PubMed ID: 25205037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
    Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
    Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells.
    Ahmed SU; Carruthers R; Gilmour L; Yildirim S; Watts C; Chalmers AJ
    Cancer Res; 2015 Oct; 75(20):4416-28. PubMed ID: 26282173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma recurrent cells switch between ATM and ATR pathway as an alternative strategy to survive radiation stress.
    Kaur E; Ketkar M; Dutt S
    Med Oncol; 2022 Feb; 39(5):50. PubMed ID: 35150325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation Drives the Evolution of Orthotopic Xenografts Initiated from Glioblastoma Stem-like Cells.
    McAbee JH; Rath BH; Valdez K; Young DL; Wu X; Shankavaram UT; Camphausen K; Tofilon PJ
    Cancer Res; 2019 Dec; 79(23):6032-6043. PubMed ID: 31615806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells.
    Venere M; Hamerlik P; Wu Q; Rasmussen RD; Song LA; Vasanji A; Tenley N; Flavahan WA; Hjelmeland AB; Bartek J; Rich JN
    Cell Death Differ; 2014 Feb; 21(2):258-69. PubMed ID: 24121277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.
    Kahn J; Hayman TJ; Jamal M; Rath BH; Kramp T; Camphausen K; Tofilon PJ
    Neuro Oncol; 2014 Jan; 16(1):29-37. PubMed ID: 24311635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells.
    Marampon F; Megiorni F; Camero S; Crescioli C; McDowell HP; Sferra R; Vetuschi A; Pompili S; Ventura L; De Felice F; Tombolini V; Dominici C; Maggio R; Festuccia C; Gravina GL
    Cancer Lett; 2017 Jul; 397():1-11. PubMed ID: 28342984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained inhibition of PARP-1 activity delays glioblastoma recurrence by enhancing radiation-induced senescence.
    Ghorai A; Mahaddalkar T; Thorat R; Dutt S
    Cancer Lett; 2020 Oct; 490():44-53. PubMed ID: 32645394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination.
    Tu Y; Chen Z; Zhao P; Sun G; Bao Z; Chao H; Fan L; Li C; You Y; Qu Y; Chen Y; Ji J
    Clin Cancer Res; 2020 Apr; 26(7):1749-1762. PubMed ID: 31900278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways.
    Bijangi-Vishehsaraei K; Reza Saadatzadeh M; Wang H; Nguyen A; Kamocka MM; Cai W; Cohen-Gadol AA; Halum SL; Sarkaria JN; Pollok KE; Safa AR
    J Neurosurg; 2017 Dec; 127(6):1219-1230. PubMed ID: 28059653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-quadruplex ligand-induced DNA damage response coupled with telomere dysfunction and replication stress in glioma stem cells.
    Hasegawa D; Okabe S; Okamoto K; Nakano I; Shin-ya K; Seimiya H
    Biochem Biophys Res Commun; 2016 Feb; 471(1):75-81. PubMed ID: 26845351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines.
    McCord AM; Jamal M; Williams ES; Camphausen K; Tofilon PJ
    Clin Cancer Res; 2009 Aug; 15(16):5145-53. PubMed ID: 19671863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAF promotes stemness and radioresistance of glioma stem cells.
    Ong DST; Hu B; Ho YW; Sauvé CG; Bristow CA; Wang Q; Multani AS; Chen P; Nezi L; Jiang S; Gorman CE; Monasterio MM; Koul D; Marchesini M; Colla S; Jin EJ; Sulman EP; Spring DJ; Yung WA; Verhaak RGW; Chin L; Wang YA; DePinho RA
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):E9086-E9095. PubMed ID: 29073105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma.
    Rasmussen RD; Gajjar MK; Jensen KE; Hamerlik P
    Mol Oncol; 2016 May; 10(5):751-63. PubMed ID: 26794465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.